Qualitative evaluation of adherence therapy in Parkinson’s disease: a multidirectional model

David James Daley1 Norwich Medical School, Faculty of Medicine and Health Sciences, University of East Anglia, Norwich Research Park;2 Norfolk and Norwich University Hospital NHS Foundation Trust, Norwich Research Park, Norwich, UKCorrespondence[email protected]

Katherine Helen O’Leary Deane3 School of Health Sciences, University of East Anglia, Norwich Research Park, Norwich, UK

Richard John Gray4 Hamad Medical Corporation, Doha, Qatar

Rebekah Hill3 School of Health Sciences, University of East Anglia, Norwich Research Park, Norwich, UK

Phyo Kyaw Myint5 Epidemiology Group, School of Medicine and Dentistry, Institute of Applied Health Sciences, College of Life Sciences and Medicine, University of Aberdeen, Aberdeen, UK

Pages 989-998 | Published online: 10 Jul 2015

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

GrossetDAntoniniACanesiMAdherence to antiparkinson medication in a multicenter European studyMov Disord20092482683219191340
PubMed Web of Science ®Google Scholar
DaleyDJMyintPKGrayRJDeaneKHSystematic review on factors associated with medication non-adherence in Parkinson’s diseaseParkinsonism Relat Disord2012181053106123022461
PubMed Web of Science ®Google Scholar
HaynesRBAcklooESahotaNMcDonaldHPYaoXInterventions for enhancing medication adherenceCochrane Database Syst Rev20082CD00001118425859
PubMed Web of Science ®Google Scholar
KripalaniSYaoXHaynesRBInterventions to enhance medication adherence in chronic medical conditions: a systematic reviewArch Intern Med200716754054917389285
PubMed Web of Science ®Google Scholar
DaleyDDeaneKGrayRThe use of carer assisted adherence therapy for people with Parkinson’s disease and their carers (CAAT-PARK): study protocol for a randomised controlled trialTrials20111225122122912
PubMed Web of Science ®Google Scholar
DaleyDJDeaneKHGrayRJAdherence therapy improves medication adherence and quality of life in people with Parkinson’s disease: a randomised controlled trialInt J Clin Pract20146896397124750544
PubMed Web of Science ®Google Scholar
GrayRWhiteJSchulzMAbderhaldenCEnhancing medication adherence in people with schizophrenia: an international programme of researchInt J Ment Health Nurs201019364420074202
PubMed Web of Science ®Google Scholar
GrayRLeeseMBindmanJAdherence therapy for people with schizophrenia. European multicentre randomised controlled trialBr J Psychiatry200618950851417139034
PubMed Web of Science ®Google Scholar
GrayRAdherence therapy: working together to improve healthA treatment manual for healthcare workersUniversity of East Anglia2011 Available from: http://www.academia.edu/2436503/Adherence_therapy_manualAccessed June 12, 2015
Google Scholar
BraunVClarkeVUsing thematic analysis in psychologyQual Res Psychol2006377101
Google Scholar
BadcottDThe expert patient: valid recognition or false hope?Med Health Care Philos2005817317816215797
PubMedGoogle Scholar
DreyNMcKeownEKellyDGouldDAdherence to antiparkinsonian medication: an in-depth qualitative studyInt J Nurs Stud20124986387122342100
PubMed Web of Science ®Google Scholar
DimatteoMRLepperHSCroghanTWDepression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherenceArch Intern Med20001602101210710904452
PubMed Web of Science ®Google Scholar
ShibaMBowerJHMaraganoreDMAnxiety disorders and depressive disorders preceding Parkinson’s disease: a case-control studyMov Disord20001566967710928577
PubMed Web of Science ®Google Scholar
FarrellKWicksMNMartinJCChronic disease self-management improved with enhanced self-efficacyClin Nurs Res20041328930815448281
PubMedGoogle Scholar
VitaleCPellecchiaMTGrossiDUnawareness of dyskinesias in Parkinson’s and Huntington’s diseasesNeurol Sci20012210510611487181
PubMed Web of Science ®Google Scholar
SitekEJSlawekJWieczorekDSelf-awareness of deficits in Huntington’s and Parkinson’s diseasePsychiatr Pol200842393403 Polish19899567
PubMed Web of Science ®Google Scholar
HorneRWeinmanJPatients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illnessJ Psychosom Res19994755556710661603
PubMed Web of Science ®Google Scholar
AlhalaiqaFDeaneKHNawaflehAHClarkAGrayRAdherence therapy for medication non-compliant patients with hypertension: a randomised controlled trialJ Hum Hypertens20112611712621326328
PubMed Web of Science ®Google Scholar
ArnoldRRanchorAVDejongsteMJThe relationship between self-efficacy and self-reported physical functioning in chronic obstructive pulmonary disease and chronic heart failureBehav Med20053110711516252622
PubMed Web of Science ®Google Scholar
GrayRWykesTEdmondsMLeeseMGournayKEffect of a medication management training package for nurses on clinical outcomes for patients with schizophrenia: cluster randomised controlled trialBr J Psychiatry200418515716215286068
PubMed Web of Science ®Google Scholar
SookaneknunPRichardsRMSanguansermsriJTeerasutCPharmacist involvement in primary care improves hypertensive patient clinical outcomesAnn Pharmacother2004382023202815522983
PubMed Web of Science ®Google Scholar
A’CampoLESpliethoff-KammingaNGMachtMEduPark ConsortiumRoosRACaregiver education in Parkinson’s disease: formative evaluation of a standardized program in seven European countriesQual Life Res201019556419946755
PubMed Web of Science ®Google Scholar
DeaneKHFlahertyHDaleyDJPriority setting partnership to identify the top 10 research priorities in Parkinson’s diseaseBMJ Open2014412e006434
PubMed Web of Science ®Google Scholar
SchapiraAHEmreMJennerPPoeweWLevodopa in the treatment of Parkinson’s diseaseEur J Neurol20091698298919538218
PubMed Web of Science ®Google Scholar
MolloySARowanENO’BrienJTEffect of levodopa on cognitive function in Parkinson’s disease with and without dementia and dementia with Lewy bodiesJ Neurol Neurosurg Psychiatry2006771323132816952917
PubMed Web of Science ®Google Scholar
KulisevskyJGarcia-SanchezCBerthierMLChronic effects of dopaminergic replacement on cognitive function in Parkinson’s disease: a two-year follow-up study of previously untreated patientsMov Disord20001561362610928571
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Qualitative evaluation of adherence therapy in Parkinson’s disease: a multidirectional model

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Qualitative evaluation of adherence therapy in Parkinson’s disease: a multidirectional model

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date